Peptides
BPC-157 and TB-500 together: why we don't sell the stack
8 min read ·
The phrase BPC-157 TB-500 is mostly a human search. People stack the two peptides, swap notes, and look for a vendor. A dog owner who lands on that query still deserves a page written for the animal in the house, not for a bodybuilding forum.
Better Years' answer is not a combo vial. Restore is injectable BPC-157 for dogs, with the evidence classified in public. TB-500 stays on the watchlist because the direct therapeutic evidence is weaker than the internet volume. Peptides are the wedge. Pet longevity is the category. The stack is not the company.
Two compounds, two badges, one product decision
BPC-157 we classify as preclinical: rodent efficacy plus canine pharmacokinetic and toxicology work, not proven companion-dog benefit. TB-500 we classify as investigational. Combining them does not upgrade the evidence. A stack is still only as strong as the weakest claim you are willing to make out loud. That is why Restore does not include TB-500.
We will not use internet nicknames as a product name. Restore is BPC-157. The evidence is the constraint.
Why a waitlist instead of a cart
Restore is not for sale yet. Exact milligram amounts, reconstitution, sourcing, and fulfillment will be published before live shipping. Until then, the honest conversion is an email, not a credit card. Join the waitlist if you want BPC-157, labeled, with a veterinarian in the conversation.
Read next
If you want the single-compound pages, read BPC-157 for dogs and TB-500 for dogs. If you want the category, read peptides without the hype and what pet longevity actually means. If you want the first protocol, Restore is waiting.
Sources
- BPC-157 indexed literature, PubMed Source
Published work is predominantly laboratory and rodent-model research, plus some canine pharmacokinetic and toxicology studies. A literature search is not a companion-dog efficacy trial. We classify companion-dog efficacy as preclinical.
- Thymosin beta-4 indexed literature, PubMed Source
TB-500 is discussed as a fragment related to thymosin beta-4. That is not FDA approval for dogs and not a proven clinical outcome.
Questions people actually ask
Online, people combine BPC-157 and TB-500 and talk about recovery. That is a human forum habit, not a Better Years product. Restore is injectable BPC-157. TB-500 is on the research watchlist. Evidence in dogs is preclinical to investigational. It is not FDA approved for this use.